Wu Cheng Yu - Net Worth and Insider Trading

Wu Cheng Yu Net Worth

The estimated net worth of Wu Cheng Yu is at least $0 dollars as of 2025-06-26. Wu Cheng Yu is the Directors, executives of Tonghua Golden-horse Pharmaceutical Industry Co Ltd and owns about 0 shares of Tonghua Golden-horse Pharmaceutical Industry Co Ltd (SZSE:000766) stock worth over $0. Details can be seen in Wu Cheng Yu's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wu Cheng Yu has not made any transactions after 2011-08-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Wu Cheng Yu

Wu Cheng Yu Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Wu Cheng Yu owns 1 companies in total, including Tonghua Golden-horse Pharmaceutical Industry Co Ltd (SZSE:000766) .

Click here to see the complete history of Wu Cheng Yu’s form 4 insider trades.

Insider Ownership Summary of Wu Cheng Yu

Ticker	Company	Transaction Date	Type of Owner
SZSE:000766	Tonghua Golden-horse Pharmaceutical Industry Co Ltd	2011-08-25	Directors & executives

Wu Cheng Yu Latest Holdings Summary

Wu Cheng Yu currently owns a total of 1 stock. Wu Cheng Yu owns 0 shares of Tonghua Golden-horse Pharmaceutical Industry Co Ltd (SZSE:000766) as of August 25, 2011, with a value of $0.

Latest Holdings of Wu Cheng Yu

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SZSE:000766	Tonghua Golden-horse Pharmaceutical Industry Co Ltd	2011-08-25	0	25.53	0

Holding Weightings of Wu Cheng Yu

Wu Cheng Yu Form 4 Trading Tracker

According to the SEC Form 4 filings, Wu Cheng Yu has made a total of 0 transactions in Tonghua Golden-horse Pharmaceutical Industry Co Ltd (SZSE:000766) over the past 5 years. The most-recent trade in Tonghua Golden-horse Pharmaceutical Industry Co Ltd is the sale of 3,800 shares on August 25, 2011, which brought Wu Cheng Yu around $32,034.

Insider Trading History of Wu Cheng Yu

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Wu Cheng Yu Trading Performance

GuruFocus tracks the stock performance after each of Wu Cheng Yu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wu Cheng Yu is 3.62%. GuruFocus also compares Wu Cheng Yu's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wu Cheng Yu within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Wu Cheng Yu's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Wu Cheng Yu

Average Return

Average return per transaction

Outperforming Transactions

1 out of 3 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-13.78
Relative Return to S&P 500(%)	-9.22

Wu Cheng Yu Ownership Network

Ownership Network List of Wu Cheng Yu

No Data

Ownership Network Relation of Wu Cheng Yu

Wu Cheng Yu Owned Company Details

What does Tonghua Golden-horse Pharmaceutical Industry Co Ltd do?

Who are the key executives at Tonghua Golden-horse Pharmaceutical Industry Co Ltd?

Wu Cheng Yu is the Directors & executives of Tonghua Golden-horse Pharmaceutical Industry Co Ltd. Other key executives at Tonghua Golden-horse Pharmaceutical Industry Co Ltd include Supervisors Zhang De Ju , and Supervisors Li Ju .

Tonghua Golden-horse Pharmaceutical Industry Co Ltd (SZSE:000766) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tonghua Golden-horse Pharmaceutical Industry Co Ltd (SZSE:000766) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tonghua Golden-horse Pharmaceutical Industry Co Ltd (SZSE:000766) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tonghua Golden-horse Pharmaceutical Industry Co Ltd (SZSE:000766)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tonghua Golden-horse Pharmaceutical Industry Co Ltd Insider Transactions

No Available Data

Wu Cheng Yu Mailing Address

Above is the net worth, insider trading, and ownership report for Wu Cheng Yu. Currently GuruFocus does not have mailing address information for Wu Cheng Yu.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.